TY - JOUR
AU - Shipman, K.E.
AB - BJD Letters to the Editor British Journal of Dermatology The positive impact of the new National key therapeutic targets in the treatment of lipids in the Institute for Health and Care Excellence lipid prevention of CVD. LDL is the major blood lipoprotein guidelines on cardiovascular disease risk containing cholesterol and associated with atherosclerosis. management in patients with psoriasis However, LDL is not directly measured routinely, its calcula- tion is sensitive to high levels of triglycerides, and triglyc- DOI: 10.1111/bjd.13950 eride-containing lipoproteins also contribute to CVD risk. High-density lipoprotein (HDL) cholesterol is the only DEAR EDITOR, The National Institute for Health and Care nonatherogenic lipid particle. A substantial change in the new Excellence (NICE) CG67 lipid modification guidelines have guidelines is the recommendation to use non-HDL cholesterol recently been revised (to CG181, published July 2014). A to assess CVD risk instead of LDL cholesterol. major change to these guidelines, due to the overwhelming Many clinical laboratories have now started to report evidence in its favour, is the lowering of the treatment thresh- non-HDL cholesterol within the lipid profile, but not all. old for statins in primary prevention of cardiovascular disease However, even if not reported, non-HDL cholesterol is very (CVD) 
TI - The positive impact of the new National Institute for Health and Care Excellence lipid guidelines on cardiovascular disease risk management in patients with psoriasis
JF - British Journal of Dermatology
DO - 10.1111/bjd.13950
DA - 2015-11-01
UR - https://www.deepdyve.com/lp/oxford-university-press/the-positive-impact-of-the-new-national-institute-for-health-and-care-0EDt7fO3I4
SP - 1327
EP - 1328
VL - 173
IS - 5
DP - DeepDyve
ER -